THE EFFECT OF SOCIO-DEMOGRAPHIC FEATURES AND PERCEIVED SOCIAL SUPPORT ON TREATMENT COMPLIANCE IN PATIENTS WITH MULTIPLE SCLEROSIS
-
Published:2022-08-08
Issue:
Volume:
Page:
-
ISSN:2645-9094
-
Container-title:International Journal of Disabilities Sports & Health Sciences
-
language:en
-
Short-container-title:International Journal of Disabilities Sports and Health Sciences
Author:
YALÇIN Gizem Yağmur1, BESER Ayşe2
Affiliation:
1. Florence Nightingale Faculty of Nursing, Istanbul University-Cerrahpasa 2. KOÇ ÜNİVERSİTESİ, HEMŞİRELİK FAKÜLTESİ
Abstract
Multiple sclerosis (MS) is a severe autoimmune illness that can be treated with a variety of medications. However, over a third of patients do not adhere to their treatment regimens. Drug compliance may be influenced by social support and demographic factors. This is a cross-sectional study that examines the association between MS patients' socio-demographic characteristics and social support and their treatment adherence. We used the perceived social support scale and the treatment compliance scale to collect data on socio-demographic factors. We looked at the correlations between the scores on the three scales.. We included 155 female, 45 male patients in our study. The mean age of the patients was 36.3±11.8 (±standard deviation). The rate of noncompliant patients was 15.5%. and 56.0% showed moderate-level compliance with their treatment. The mean multi-dimensional perceived social support score was 62.3±18.8. The only socio-demographic feature that impacts the social support and special person subscale scores was the marital status. We found that married patiens had significantly more social support and were significantly higher than divorced patient (p
Publisher
International Journal of Disabilities Sports and Health Sciences
Reference31 articles.
1. 1. Sabaté, E., & Sabaté, E. (Eds.). (2003). Adherence to long-term therapies: evidence for action. World Health Organization. 2. 2. Tavares, N. U. L., Bertoldi, A. D., Mengue, S. S., Arrais, P. S. D., Luiza, V. L., Oliveira, M. A., ... & Pizzol, T. D. S. D. (2016). Factors associated with low adherence to medicine treatment for chronic diseases in Brazil. Revista de Saúde Pública, 50, 10s. 3. 3. Cunningham, A., Gottberg, K., Von Koch, L., & Hillert, J. (2010). Non‐adherence to interferon‐beta therapy in Swedish patients with multiple sclerosis. Acta neurologica scandinavica, 121(3), 154-160. 4. 4. DiMatteo, M. R. (2004). Social support and patient adherence to medical treatment: a meta-analysis. Health psychology, 23(2), 207. 5. 5. Fernández, O., Agüera, J., Izquierdo, G., Millán-Pascual, J., Ramio i Torrenta, L., Oliva, P., ... & Group on Adherence to IFNb-1b in Spain. (2012). Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain. PLoS One, 7(5), e35600.
|
|